These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
292 related articles for article (PubMed ID: 1829461)
1. Plasminogen activation by receptor-bound urokinase. A kinetic study with both cell-associated and isolated receptor. Ellis V; Behrendt N; Danø K J Biol Chem; 1991 Jul; 266(19):12752-8. PubMed ID: 1829461 [TBL] [Abstract][Full Text] [Related]
2. Integrin alphaMbeta2 orchestrates and accelerates plasminogen activation and fibrinolysis by neutrophils. Pluskota E; Soloviev DA; Bdeir K; Cines DB; Plow EF J Biol Chem; 2004 Apr; 279(17):18063-72. PubMed ID: 14769799 [TBL] [Abstract][Full Text] [Related]
3. Receptor-mediated regulation of plasminogen activator function: plasminogen activation by two directly membrane-anchored forms of urokinase. Vines DJ; Lee SW; Dichek DA; Ellis V J Pept Sci; 2000 Sep; 6(9):432-9. PubMed ID: 11016879 [TBL] [Abstract][Full Text] [Related]
4. Kinetics of reciprocal pro-urokinase/plasminogen activation--stimulation by a template formed by the urokinase receptor bound to poly(D-lysine). Petersen LC Eur J Biochem; 1997 Apr; 245(2):316-23. PubMed ID: 9151959 [TBL] [Abstract][Full Text] [Related]
6. Functional analysis of the cellular receptor for urokinase in plasminogen activation. Receptor binding has no influence on the zymogenic nature of pro-urokinase. Ellis V J Biol Chem; 1996 Jun; 271(25):14779-84. PubMed ID: 8662951 [TBL] [Abstract][Full Text] [Related]
7. Characterization of the cellular binding site for the urokinase-type plasminogen activator. Estreicher A; Wohlwend A; Belin D; Schleuning WD; Vassalli JD J Biol Chem; 1989 Jan; 264(2):1180-9. PubMed ID: 2536017 [TBL] [Abstract][Full Text] [Related]
8. Generation of cell surface-bound plasmin by cell-associated urokinase-type or secreted tissue-type plasminogen activator: a key event in melanoma cell invasiveness in vitro. Meissauer A; Kramer MD; Schirrmacher V; Brunner G Exp Cell Res; 1992 Apr; 199(2):179-90. PubMed ID: 1531956 [TBL] [Abstract][Full Text] [Related]
9. Tranexamic acid mediates proinflammatory and anti-inflammatory signaling via complement C5a regulation in a plasminogen activator-dependent manner. Barrett CD; Moore HB; Kong YW; Chapman MP; Sriram G; Lim D; Moore EE; Yaffe MB J Trauma Acute Care Surg; 2019 Jan; 86(1):101-107. PubMed ID: 30575685 [TBL] [Abstract][Full Text] [Related]
10. Cathepsin B efficiently activates the soluble and the tumor cell receptor-bound form of the proenzyme urokinase-type plasminogen activator (Pro-uPA). Kobayashi H; Schmitt M; Goretzki L; Chucholowski N; Calvete J; Kramer M; Günzler WA; Jänicke F; Graeff H J Biol Chem; 1991 Mar; 266(8):5147-52. PubMed ID: 1900515 [TBL] [Abstract][Full Text] [Related]
11. Accessibility of receptor-bound urokinase to type-1 plasminogen activator inhibitor. Cubellis MV; Andreasen P; Ragno P; Mayer M; Danø K; Blasi F Proc Natl Acad Sci U S A; 1989 Jul; 86(13):4828-32. PubMed ID: 2544876 [TBL] [Abstract][Full Text] [Related]
12. Tissue plasminogen activator and urokinase enhance the binding of plasminogen to thrombospondin. Silverstein RL; Harpel PC; Nachman RL J Biol Chem; 1986 Jul; 261(21):9959-65. PubMed ID: 2942536 [TBL] [Abstract][Full Text] [Related]
13. Activation of pro-urokinase and plasminogen on human sarcoma cells: a proteolytic system with surface-bound reactants. Stephens RW; Pöllänen J; Tapiovaara H; Leung KC; Sim PS; Salonen EM; Rønne E; Behrendt N; Danø K; Vaheri A J Cell Biol; 1989 May; 108(5):1987-95. PubMed ID: 2523891 [TBL] [Abstract][Full Text] [Related]
14. Plasminogen activator system modulates invasive capacity and proliferation in prostatic tumor cells. Festuccia C; Dolo V; Guerra F; Violini S; Muzi P; Pavan A; Bologna M Clin Exp Metastasis; 1998 Aug; 16(6):513-28. PubMed ID: 9872599 [TBL] [Abstract][Full Text] [Related]
16. Function of the plasminogen/plasmin and matrix metalloproteinase systems after vascular injury in mice with targeted inactivation of fibrinolytic system genes. Lijnen HR; Van Hoef B; Lupu F; Moons L; Carmeliet P; Collen D Arterioscler Thromb Vasc Biol; 1998 Jul; 18(7):1035-45. PubMed ID: 9672063 [TBL] [Abstract][Full Text] [Related]
17. Assembly of urokinase receptor-mediated plasminogen activation complexes involves direct, non-active-site interactions between urokinase and plasminogen. Ellis V; Whawell SA; Werner F; Deadman JJ Biochemistry; 1999 Jan; 38(2):651-9. PubMed ID: 9888805 [TBL] [Abstract][Full Text] [Related]
18. Potentiation of plasminogen activation by an anti-urokinase monoclonal antibody due to ternary complex formation. A mechanistic model for receptor-mediated plasminogen activation. Ellis V; Danø K J Biol Chem; 1993 Mar; 268(7):4806-13. PubMed ID: 8444857 [TBL] [Abstract][Full Text] [Related]
19. Fibrinolytic cross-talk: a new mechanism for plasmin formation. Dejouvencel T; Doeuvre L; Lacroix R; Plawinski L; Dignat-George F; Lijnen HR; Anglés-Cano E Blood; 2010 Mar; 115(10):2048-56. PubMed ID: 19996088 [TBL] [Abstract][Full Text] [Related]
20. Specific inhibition of the activity of the urokinase receptor-mediated cell-surface plasminogen activation system by suramin. Ellis V; Danø K Biochem J; 1993 Dec; 296 ( Pt 2)(Pt 2):505-10. PubMed ID: 8257443 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]